These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6424002)

  • 21. [Treatment of resistant hypertension with captopril in children with terminal insufficiency of renal function].
    Peco-Antić A; Popović-Rolović M; Popović D; Calić-Perisić N; Mancić J
    Srp Arh Celok Lek; 1983 Mar; 111(3):341-54. PubMed ID: 6362034
    [No Abstract]   [Full Text] [Related]  

  • 22. [A clinical study on treatment of refractory heart failure with oral captopril].
    Wang ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Dec; 11(4):269-72. PubMed ID: 6370641
    [No Abstract]   [Full Text] [Related]  

  • 23. [Different changes in the adrenergic system with nitrendipine and captopril and different therapeutic aspects in treatment of hypertension and heart failure].
    Müller R; Steffen HM; Kugel C; Freiheit T; Franzen D; Wambach G; Kaufmann W
    Z Kardiol; 1991; 80 Suppl 8():109-10. PubMed ID: 1796628
    [No Abstract]   [Full Text] [Related]  

  • 24. [Severe side-effects of captopril].
    Arcavi L; Estrov Z; Caspi A; Resnitzky P
    Harefuah; 1985 May; 108(9):439-41. PubMed ID: 3896985
    [No Abstract]   [Full Text] [Related]  

  • 25. [How does one establish Tensobon (captopril) in general practice? Scientific cooperation of general practice and clinical aspects in therapeutic circles].
    Lederle RM; Riechmann G
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S24-8. PubMed ID: 6424003
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension].
    Valvo E; Previato G; Oldrizzi L; Corgnati A; Lupo A; Loschiavo C; Tessitore N; Maschio G
    Minerva Nefrol; 1981; 28(2):139-41. PubMed ID: 7027091
    [No Abstract]   [Full Text] [Related]  

  • 27. [What promotes compliance in therapy with Tensobon?].
    Schrey A
    Fortschr Med Suppl; 1985; 1():18-20. PubMed ID: 2858439
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of congestive heart failure with captopril].
    Zheng DY
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):5-9, 61. PubMed ID: 6396047
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of severe chronic cardiac congestive insufficiency with captopril. Short and long-term clinical, hemodynamic and biological effects].
    Lavigne G; Morand P
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):339-48. PubMed ID: 6807251
    [No Abstract]   [Full Text] [Related]  

  • 31. [Value of combination therapy with Tensobon].
    Lederle RM
    Fortschr Med Suppl; 1985; 1():6-11. PubMed ID: 2858442
    [No Abstract]   [Full Text] [Related]  

  • 32. Captopril--a new agent for hypertension.
    S Afr Med J; 1979 Dec; 56(23):977-8. PubMed ID: 399092
    [No Abstract]   [Full Text] [Related]  

  • 33. [Every 2d patient can be controlled with monotherapy. Multicenter study with Tensobon in general practice].
    Haase W
    Fortschr Med Suppl; 1985; 1():16-7. PubMed ID: 2858438
    [No Abstract]   [Full Text] [Related]  

  • 34. [Captopril in renal artery stenoses and renal insufficiency].
    Kirchertz EJ; Scheler F
    Internist (Berl); 1982 Apr; 23(4):237-40. PubMed ID: 7045027
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of captopril in the management of hypertension after renal transplantation.
    Waltzer WC; Anaise D; Arbeit L; Weinstein S; Rapaport FT
    Transplant Proc; 1984 Oct; 16(5):1372-4. PubMed ID: 6385423
    [No Abstract]   [Full Text] [Related]  

  • 36. Captopril: clinical pharmacology and benefit-to-risk ratio in hypertension and congestive heart failure.
    Vlasses PH; Ferguson RK; Chatterjee K
    Pharmacotherapy; 1982; 2(1):1-17. PubMed ID: 6765388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Captopril treatment of refractory hypertension in children.
    Chan LL; Balfe JW; Hardy BE
    Can Med Assoc J; 1981 Feb; 124(3):255-9. PubMed ID: 7006786
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical pharmacology of captopril].
    Lazowski J
    Pol Tyg Lek; 1983 Nov; 38(45):1393-7. PubMed ID: 6374633
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.
    Björck S; Herlitz H; Nyberg G; Granerus G; Aurell M
    Hypertension; 1983; 5(5 Pt 2):III152-3. PubMed ID: 6354931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.